tiprankstipranks
Trending News
More News >
InnoCan Pharma (TSE:INNO)
:INNO
Canadian Market

InnoCan Pharma (INNO) Income Statement

Compare
21 Followers

InnoCan Pharma Income Statement

Last quarter (Q3 2025), InnoCan Pharma's total revenue was $9.40M, an increase of 8.95% from the same quarter last year. In Q3, InnoCan Pharma's net income was $-1.95M. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 29.44M$ 13.66M$ 2.56M$ 196.00K$ 8.00K
Gross Profit
$ 26.19M$ 11.98M$ 2.11M$ 121.00K$ 3.00K
Operating Expenses
$ 27.43M$ 8.18M$ 8.37M$ 7.60M$ 4.73M
Depreciation and Amortization
$ 35.00K$ 33.00K$ 35.00K$ 43.00K$ 40.00K
EBITDA
$ 961.00K$ -3.77M$ -3.85M$ -10.04M$ -9.90M
Operating Income
$ -1.25M$ 3.80M$ -6.27M$ -7.48M$ -4.72M
Other Income/Expenses
$ 2.17M$ -7.84M$ 2.38M$ -2.61M$ -5.23M
Pretax Income
$ 919.00K$ -4.03M$ -3.89M$ -10.09M$ -9.95M
Net Income
$ -1.83M$ -4.70M$ -3.89M$ -10.06M$ -15.18M
Per Share Metrics
Basic EPS
$ -0.42$ -1.19$ -1.01$ -2.91$ -6.09
Diluted EPS
$ -0.42$ -1.19$ -1.01$ -2.91$ -6.09
Weighted Average Shares Outstanding
4.20M----
Weighted Average Shares Outstanding (Diluted)
4.20M----
Currency in USD

InnoCan Pharma Earnings and Revenue History